Delivery Order HHSN261201700010I-HHSN26100004

Ended Awarded Last action

Contract number
HHSN26100004
Awardee
Awarding agency
Obligated
$17,786

Award facts

Opportunity
Contract value 100% obligated
$17,786.27 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on October 24, 2017, for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers, with a ceiling value of $17,786.27.

Place of performance is Bethesda, MD 20892. The order carries a firm fixed price and an ultimate completion date of October 30, 2017. No set-aside was used.

Quick answers

Who was awarded contract HHSN26100004?

HHSN26100004 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on October 24, 2017.

How much is contract HHSN26100004 worth?

The government has obligated $17,786 on HHSN26100004.

Is contract HHSN26100004 an order under another contract?

Yes. HHSN26100004 is a delivery order under HHSN261201700010I, an indefinite delivery contract.

Was contract HHSN26100004 competed?

The extent of competition for HHSN26100004 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login